Timber Pharmaceuticals Inc (NY:TMBR)

N/A UNCHANGED

Last Price Updated: 8:00 PM EST, Nov 28, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Timber Pharmaceuticals Inc

< Previous 1 2 3 4 5 Next >

Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results

March 31, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 27, 2023

Via Benzinga

Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology

March 20, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 03, 2023

We're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on!

Via InvestorPlace

Dow Dips 350 Points; S&P 500 Down Over 1% ↗

February 24, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Friday. The Dow traded down 1.07% to 32,798.91 while the NASDAQ fell 1.90% to 11,370.53. The S&P 500...

Via Benzinga

Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 24, 2023

Gainers Bridger Aerospace Group Holdings, Inc. (NASDAQ: BAER) shares jumped 129.6% to $10.15. Jeffrey E. Kelter reported a 22.4% stake in a 13D filing on Thursday.

Via Benzinga

Timber Pharmaceuticals (NYSE American: TMBR) Granted Orphan Drug Designation in Europe for TMB-001

February 24, 2023

Timber Pharmaceuticals, Inc. (NYSE American: TMBR) is engaged as a clinical-stage biopharmaceutical company, which is focused on the development and

Via Spotlight Growth

Nasdaq Tumbles 2%; Timber Pharmaceuticals Shares Spike Higher ↗

February 24, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 450 points on Friday. The Dow traded down 1.39% to 32,692.94 while the NASDAQ fell 2.14% to 11,342.36. The S&P 500 also...

Via Benzinga

Why Is Timber Pharmaceuticals (TMBR) Stock Up 61% Today? ↗

February 24, 2023

Timber Pharmaceuticals (TMBR) stock is taking off on Friday after getting an orphan drug designation for TMB-001 in Europe.

Via InvestorPlace

Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive Ichthyosis

February 24, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 04, 2023

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive...

Via Benzinga

Timber Pharmaceuticals to Host Investor Business Briefing: Milestone Achievements and Forward Outlook

December 14, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Timber Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards

December 09, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Stocks That Hit 52-Week Lows On Monday ↗

November 28, 2022

On Monday, 79 companies reached new 52-week lows.

Via Benzinga

Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2022 Financial Results

November 14, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Stocks That Hit 52-Week Lows On Wednesday ↗

November 09, 2022

On Wednesday, 283 companies set new 52-week lows.

Via Benzinga

Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday ↗

November 10, 2022

Gainers

Via Benzinga

Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session ↗

November 09, 2022

Gainers

Via Benzinga

Timber Pharmaceuticals, Inc. Announces 1-for-50 Reverse Stock Split

November 08, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Timber Pharmaceuticals Announces Halt of Common Stock Trading

November 03, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Timber Pharmaceuticals Receives European Orphan Designation for Autosomal Recessive Congenital Ichthyosis & Positive Comments on Pediatric Investigation Plan for TMB-001 in Autosomal Recessive CI & X-Linked Recessive Ichthyosis

October 25, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Nasdaq Jumps 270 Points; Silver Surges Over 8% ↗

October 03, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 270 points on Monday.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

October 28, 2022

During Friday, 125 stocks hit new 52-week lows.

Via Benzinga

October 04, 2022

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per...

Via Benzinga

Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session ↗

October 03, 2022

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.

Via Benzinga

S&P 500 Surges 2%; Crude Oil Rises Sharply ↗

October 03, 2022

U.S. stocks extended gains midway through trading, with the Dow Jones gaining more than 600 points on Monday.

Via Benzinga

Why Timber Pharmaceuticals Shares Are Getting Hammered ↗

October 03, 2022

Timber Pharmaceuticals Inc (NASDAQ: TMBR) shares are trading lower by 20.09% to $0.09 Monday morning after the company announced a $1.3 million registered direct offering. What Else?

Via Benzinga

Timber Pharmaceuticals Announces $1.3 Million Registered Direct Offering

October 03, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket ↗

September 22, 2022

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem...

Via Benzinga

Timber Pharmaceuticals Receives Positive Opinion on Orphan Designation from European Medicines Agency for TMB-001 for Treatment of Autosomal Recessive Congenital Ichthyosis

September 14, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.